Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application for felodipine extended-release tablets USP, 2.5mg, 5mg and 10mg, for the treatment of hypertension.
Subscribe to our email newsletter
Felodipine extended-release tablets are the generic version of AstraZeneca Pharmaceutical’s Plendil extended-release tablets.
The company will begin shipping the product immediately.